My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Thalassemia major: molecular and clinical aspects. NIH Conference.

    [No authors listed]

    Ann Intern Med. 1979 Dec;91(6):883-97. Review.PMID: 391118 [PubMed - indexed for MEDLINE]Related articles

    2.

    Thalassemia.

    Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E.

    Hematology Am Soc Hematol Educ Program. 2004:14-34. Review.PMID: 15561674 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.

    Giardina PJ, Grady RW.

    Semin Hematol. 1995 Oct;32(4):304-12. Review.PMID: 8560288 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of cardiac function in patients with thalassemia major.

    Nienhuis AW, Griffith P, Strawczynski H, Henry W, Borer J, Leon M, Anderson WF.

    Ann N Y Acad Sci. 1980;344:384-96.PMID: 6930878 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preclinical abnormal segmental cardiac manifestations of thalassemia major in children on transfusion-chelation therapy: echographic alterations of left ventricular posterior wall contraction and relaxation patterns.

    Valdes-Cruz LM, Reinecke C, Rutkowski M, Dudell GG, Goldberg SJ, Allen HD, Sahn DJ, Piomelli S.

    Am Heart J. 1982 Apr;103(4 Pt 1):505-11.PMID: 7064792 [PubMed - indexed for MEDLINE]Related articles

    6.

    Update on thalassemia.

    Giardina PJ, Hilgartner MW.

    Pediatr Rev. 1992 Feb;13(2):55-62. Review.PMID: 1546001 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mechanisms of and obstacles to iron cardiomyopathy in thalassemia.

    Peng CT, Chang JS, Wu KH, Tsai CH, Lin HS.

    Front Biosci. 2008 May 1;13:5975-87. Review.PMID: 18508636 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with thalassemia major: a long-term follow-up study.

    Jambrik Z, Derchi G, Picano E, Ait-Ali L, Forni G, Bellotti P.

    Echocardiography. 2005 Mar;22(3):239-44.PMID: 15725159 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience.

    Peng CT, Tsai CH, Wu KH.

    Hemoglobin. 2008;32(1-2):49-62. Review.PMID: 18274983 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Chelating therapy in beta-thalassemia]

    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.

    Pediatr Med Chir. 1982 Jan-Apr;4(1-2):55-9. Italian. PMID: 7111040 [PubMed - indexed for MEDLINE]Related articles

    11.

    Influence of iron chelators on myocardial iron and cardiac function in transfusion-dependent thalassaemia: a systematic review and meta-analysis.

    Mamtani M, Kulkarni H.

    Br J Haematol. 2008 Jun;141(6):882-90. Epub 2008 Mar 18. Review.PMID: 18355381 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.

    Kolnagou A, Kontoghiorghes GJ.

    Hemoglobin. 2006;30(2):239-49.PMID: 16798649 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Clinical aspects of thalassemia (or microcythemia)]

    Bianco I.

    Minerva Med. 1981 Nov 3;72(43):2865-82. Italian. PMID: 7301167 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

    Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ.

    J Cardiovasc Magn Reson. 2008 Feb 25;10(1):12.PMID: 18298856 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.

    Ehlers KH, Giardina PJ, Lesser ML, Engle MA, Hilgartner MW.

    J Pediatr. 1991 Apr;118(4 ( Pt 1)):540-5.PMID: 2007928 [PubMed - indexed for MEDLINE]Related articles

    16.

    The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

    Aessopos A, Berdoukas V, Tsironi M.

    Eur J Haematol. 2008 Feb;80(2):93-106. Epub 2007 Dec 10. Review.PMID: 18081719 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Current status of iron chelation therapy with deferoxamine.

    Cohen A.

    Semin Hematol. 1990 Apr;27(2):86-90. Review.PMID: 2190321 [PubMed - indexed for MEDLINE]Related articles

    18.

    Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.

    Graziano JH, Piomelli S, Hilgartner M, Giardina P, Karpatkin M, Andrew M, LoIacono N, Seaman C.

    J Pediatr. 1981 Nov;99(5):695-9.PMID: 7299540 [PubMed - indexed for MEDLINE]Related articles

    19.

    Thalassemia syndromes. Recent advances.

    Ohene-Frempong K, Rappaport E, Schwartz E.

    Hematol Oncol Clin North Am. 1987 Sep;1(3):503-19. Review.PMID: 3329184 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of transfusional iron overload.

    Cohen A.

    Am J Pediatr Hematol Oncol. 1990 Spring;12(1):4-8. Review.PMID: 2178459 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity